Home Physician Home PI Adverse EffectsFor US residents only





Promiseb Promiseb™ Topical Cream for seborrheic dermatitis

Promiseb Promiseb™ Topical Cream for seborrheic dermatitis

 

 

Efficacy

Comparable efficacy to desonide cream 0.05% at days 14 and 28 (> .2) with a lower relapse rate (P < .02)1

  • Investigator global assessment (IGA) scores over time similar to desonide cream 0.05%1

No statistically significant difference between
Promiseb® Topical Cream and desonide cream 0.05%1

IGA Line Graph

(click image to enlarge)

Rapid efficacy with a lower relapse rate of
seborrheic dermatitis

Relapse Bar Graph

(click image to enlarge)
  • 71% of day 14 responders (clear) in the Promiseb Topical Cream group remained clear vs 14% in the desonide cream 0.05% group on day 28 (P < .02)1
  • Patients treated with Promiseb Topical Cream whose symptoms cleared at day 14 were less likely to relapse by day 28 than patients using desonide cream 0.05% (P < .02)1

 

 

 

 
©2019 Encore Dermatology, Inc.,
Malvern, PA 19355. All rights reserved.
www.encorederm.com